Patent Assignment
Reel/Frame 043761/0389
Patent Security Agreement
Recorded: 2017-09-05
Pages: 19
Assignor
TRIS PHARMA, INC.
Executed: 2017-08-31
Assignee
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
10 S DEARBORN, FLOOR L2, IL1-1145, CHICAGO, ILLINOIS, 60603-2300
Covered Properties
(43)
A Pharmaceutical Composition Comprising Cyclosporin in Association with a Carrier in a Self-Emulsifying Drug Delivery System
Patent:
6,057,289 →
Application:
09/303,158 →
Self-Emulsifying Compositions for Drugs Poorly Soluble in Water
Patent:
6,436,430 →
Application:
09/459,299 →
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Abuse Resistant Opioid Drug-Ion Exchange Resin Complexes Having Hybrid Coatings
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Novel Clonidine Formulation
Patent:
8,623,409 →
Application:
12/908,796 →
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Formulations Containing an Ionic Mineral-Ion Exchange Resin Complex and Uses Thereof
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Novel Clonidine Formulation
Application:
14/090,274 →
Publication:
US 2014/0093578
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Methylphenidate Extended Release Chewable Tablet
Methylphenidate Extended Release Chewable Tablet
Application:
15/009,468 →
Publication:
US 2016/0143854
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Application:
15/200,617 →
Publication:
US 2016/0310478
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Modified Release Formulations Containing Drug - Ion Exchange Resin Complexes
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Application:
15/215,276 →
Publication:
US 2017/0042873
Orally Effective Methylphenidate Extended Release Powder and Aqueous Suspension Product
Application:
15/244,430 →
Publication:
US 2017/0042874
Extended Release Amphetamine Compositions
Application:
15/258,695 →
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Benzonatate Modified Release Solid Tablets and Capsules
Application:
15/482,201 →
Methylphenidate Extended Release Chewable Tablet
Modified Release Formulations Containing Drug-Ion Exchange Resin Complexes
Related Assignments
(19)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 2, 2007
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA
Reel/Frame 019103/0030 →
Assignment of Assignor's Interest
Jul 1, 2008
From: MEHTA, KETAN; TU, YU-HSING; CHAUDHURI, ALIVIA; PERUMAL, ASHOK
To: TRIS PHARMA
Reel/Frame 021177/0143 →
Assignment of Assignor's Interest
Mar 20, 2009
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INCORPORATED
Reel/Frame 022425/0345 →
Assignment of Assignor's Interest
Dec 10, 2010
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC.
Reel/Frame 025470/0116 →
Assignment of Assignor's Interest
Apr 17, 2012
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC.
Reel/Frame 028056/0138 →
Assignment of Assignor's Interest
May 4, 2012
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA INC
Reel/Frame 028158/0060 →
Merger
Aug 1, 2012
From: PHARMASOLUTIONS, INC
To: TRIS PHARMA, INC
Reel/Frame 028698/0585 →
Assignment of Assignor's Interest
Jan 10, 2013
From: TU, YU-HSING; PERUMAL, ASHOK; MEHTA, KETAN
To: TRIS PHARMA, INC
Reel/Frame 029605/0799 →
Assignment of Assignor's Interest
Jan 22, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 029669/0483 →
Assignment of Assignor's Interest
Apr 17, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 030230/0123 →
Assignment of Assignor's Interest
Jul 23, 2013
From: MEHTA, KETAN; TU, YU-HSING; SHAH, MAHENDRA
To: TRIS PHARMA, INC
Reel/Frame 030852/0965 →
Assignment of Assignor's Interest
Aug 6, 2013
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC
Reel/Frame 030951/0411 →
Assignment of Assignor's Interest
Sep 3, 2013
From: MEHTA, KETAN; TU, YU-HSING; PERUMAL, ASHOK
To: TRIS PHARMA, INC
Reel/Frame 031124/0987 →
Assignment of Assignor's Interest
Oct 2, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 031329/0321 →
Assignment of Assignor's Interest
Oct 31, 2013
From: MEHTA, KETAN; TU, YU-HSING
To: TRIS PHARMA, INC
Reel/Frame 031521/0935 →
Grant of Security Interest in Patent Rights
Sep 24, 2018
From: TRIS PHARMA, INC.
To: DEERFIELD MANAGEMENT COMPANY, L.P., AS THE AGENT
Reel/Frame 047140/0290 →
Notice of Release of Security Interest in Patents
Sep 25, 2018
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: TRIS PHARMA, INC.
Reel/Frame 047150/0169 →
Release of Security Interest
Sep 26, 2024
From: DEERFIELD MANAGEMENT COMPANY, L.P.
To: TRIS PHARMA, INC.; NEXTWAVE PHARMACEUTICALS INCORPORATED
Reel/Frame 069054/0362 →
Security Interest
Sep 26, 2024
From: TRIS PHARMA, INC.; PARK THERAPEUTICS, INC.
To: PROVIDENT BANK
Reel/Frame 069065/0576 →